2014 Agilent Early Career Professor Award
Finalists Announced for the 2014 Agilent Early Career Professor Award:
Congratulations to each of the finalists for the 2014 Agilent Early Career Professor Award for rising to the top of a very competitive nomination process.
- John Albeck, University of California, Davis
- Paul Blainey, MIT
- Nicholas Navin, University of Texas
- Jeremy Purvis, University of North Carolina, Chapel Hill
- Adam de la Zerda, Stanford University
The purpose of the Agilent Early Career Professor Award is to:
- Promote and encourage excellent research enabling measurements of importance to Agilent Technologies and the world
- Establish strong collaborative relationships between Agilent researchers and leading professors early in their career
- Build the prominence of Agilent as a sponsor of university research
- Significant original research contributions enabling measurements of importance to Agilent Technologies and the world
- Outstanding potential for future research
- 2014 focus: Contributions to the development of advanced single-cell measurement technologies for investigating molecular properties and dynamics in populations of cells
- Professor completed Ph.D. or M.D. less than 10 years before January 1, 2014
- An unrestricted research award of $50,000 per year for 2 years to university in the professor's name
- Option to use all or part of award to obtain Agilent products at 50% discount
- Option to accelerate payments to facilitate procurement of equipment with list price over $100k
- Engraved plaque commemorating award
- Recognition on Agilent's website
- The nomination form requires contact information, a summary of the nominee's qualifications and future directions (up to 1000 words), a nomination letter (up to 500 words) and a CV. Self-nominations are encouraged. Please do not include any proprietary information.
- Completed nomination form is sent to Agilent University Relations:
Nomination deadline - January 23, 2014
- Finalists (no more than five) are chosen from the pool of nominees by the Agilent Early Career Professor Award Committee using the criteria above. The Award Committee is appointed by Director of University Relations and External Research. Finalists are announced by February 7, 2014.
- Finalists are to submit two letters of recommendation addressing why the candidate is an excellent match to the award selection criteria along with a photo. Deadline - March 21, 2014.
- The award winner will be announced by May 9, 2014.
- Award is bestowed upon professor in suitable ceremony. The winner's photo will be posted on the website.
- Winner is invited to make a presentation at an Agilent site (at Agilent’s expense).
- Past and present winners’ names are posted on the Agilent website along with articles highlighting the principal academic contributions for which the awardees were selected.
2013 Agilent Early Career Professor Award Winner
2013 Focus: Contributions to cancer diagnostics aimed at multi-analyte tools for proteomic and/or genomic biomarkers in pathology
Jindan Yu, M.B., Ph.D.
Department of Medicine
Division of Hematology/Oncology
Chicago, IL 60611
Dr. Yu joined the faculty of the Department of Medicine, Division of Hematology/Oncology at Northwestern University in 2009 as an Assistant Professor. The aim of her research program at Northwestern University is to use genomics and bioinformatics approaches to decipher the mechanisms underlying prostate tumorigenesis and to identify therapeutic targets as well as biomarkers for prostate cancer diagnostics and prognostics.
Prostate cancer affects a large percentage of the male population, but there is a wide variation in the growth rate of the tumors. Currently there are no reliable tests for distinguishing between the different types of prostate cancer. Dr. Yu’s work studies the genetics and epigenetics of different prostate tumor types with the aim of developing better tests for predicting the likely rate of tumor growth.
Dr. Yu uses genome-wide technologies to measure cancer biology and deep sequencing to reveal distinct patterns of DNA methylation during various stages of prostate cancer progression. She is investigating whether the differentially methylated regions identified can predict the future course of the disease.
Dr. Yu received a Bachelor of Medicine degree in 1998 from Peking University. She received her M.S. in Statistics in 2003 and her Ph.D. in Biomedical Engineering in 2004 from the University of Michigan. From 2004 to 2007 she worked at the HHMI and Michigan Center for Translational Pathology under Dr. Arul M. Chinnaiyan, M.D., Ph.D.